Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW   Report issue

Foundation Phase 3 Phase 4
Founded: Landegem Belgium

Organization Overview

First Clinical Trial
2020
NCT04245215
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW | BIRD (Belgian IBD Research and Development) vzw